Last reviewed · How we verify
NCT04358198
AI in GIM Diagnosis
NA trial testing Artificial intelligence in GIM Diagnosis in 120 participants. Status unknown.
30 November 2023
Quick facts
| Lead sponsor | King Chulalongkorn Memorial Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 120 |
| Start date | 1 May 2020 |
| Primary completion | 30 November 2023 |
| Estimated completion | 28 February 2024 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Artificial intelligence
Conditions studied
- GIM Diagnosis — all drugs for GIM Diagnosis →
- Artificial Intellegence — all drugs for Artificial Intellegence →
Sponsor
King Chulalongkorn Memorial Hospital
Who can join
18 and older, any sex, with GIM Diagnosis or Artificial Intellegence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will use artificial intelligence (AI) for diagnosing gastric intestinal metaplasia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Real-time semantic segmentation of gastric intestinal metaplasia using a deep learning approach.
Siripoppohn V, Pittayanon R, Tiankanon K, Faknak N, et al · · 2022 · cited 12× · PMID 35534933 · DOI 10.5946/ce.2022.005
Verify or expand the search:
- PubMed search for NCT04358198
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Artificial intelligence
Trials testing the same drug.
- NCT06268418 — Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy · completed
- NCT06667635 — Intelligent Analysis and Clinical Validation of Cerebral Small Vessel Disease on Magnetic Resonance Imaging：A Multi-cent · not yet recruiting
- NCT06942130 — The Application of Artificial Intelligence in Dental Education · NA · completed
- NCT05985057 — A Novel Approach to Antimicrobial Resistance: Machine Learning Predictions for Carbapenem-Resistant Klebsiella in ICUs · completed
- NCT06051682 — Optimization of the Diagnosis of Bone Fractures in Patients Treated in the Emergency Department by Using Artificial Inte · NA · unknown
Other recruiting trials for GIM Diagnosis
Currently open trials in the same condition.
- NCT07229833 — Validation of Fitbit Measurements in Hospitalized General Medicine Patients · active not recruiting
Other King Chulalongkorn Memorial Hospital trials
Trials by the same sponsor.
- NCT07171853 — The Carbon Footprint Study of Colonoscopy · recruiting
- NCT07261228 — The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper · recruiting
- NCT06906835 — Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis · NA · recruiting
- NCT06030609 — The Comparison Between Ringer Lactate Solution and Normal Saline With Dextrose Water in Post-Operative Period of Kidney · Phase 3 · completed
- NCT06288828 — The Efficacy of Aerobic Exercise Training on Autonomic Nervous System and Endothelial Function in Patients with Compensa · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04358198 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Chulalongkorn Memorial Hospital
- Last refreshed: 31 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04358198.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing